Gregoire Ramade - May 10, 2022 Form 4 Insider Report for VAPOTHERM INC (VAPO)

Role
SVP and Chief Comm Officer
Signature
/s/Adrain Bryant, as Attorney In Fact
Stock symbol
VAPO
Transactions as of
May 10, 2022
Transactions value $
$0
Form type
4
Date filed
5/12/2022, 09:30 PM
Previous filing
Jan 4, 2022
Next filing
Nov 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VAPO Common Stock 33.1K May 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VAPO Stock Option (right to buy) Award $0 +53K $0.00 53K May 10, 2022 Common Stock 53K $3.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 19,900 shares that will be issued over time upon vesting and settlement of restricted stock units granted under the Vapotherm, Inc. 2018 Equity Incentive Plan (as amended from time to time, the "2018 Equity Plan") and the Vapotherm, Inc. Amended and Restated 2019 French Qualifying Sub Plan (the "French Sub Plan").
F2 This option was granted under the 2018 Equity Plan and the French Sub Plan and will vest as to 25% of the underlying shares on January 1, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting dates.